Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications /
The concept of delivering ‘magic bullets’ to treat diseases was first proposed by Paul Erlich in the early 1900’s. The realization of this concept for the treatment of cancer occurred in the late 1990’s with the approval of monoclonal antibody therapies. The use of monoclonal antibodies conjugated...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Phillips, Gail Lewis (Editor) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Series: | Cancer Drug Discovery and Development
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins
Published: (2017) -
Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance /
Published: (2013) -
Bispecific Antibodies
Published: (2011) -
Metastasis of Colorectal Cancer
Published: (2010) -
Drugs for HER-2-positive Breast Cancer
Published: (2011)